|
|
Volumn 92, Issue 11, 2000, Pages 859-860
|
|
Combined endocrine therapy for breast cancer - New life for an old idea?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AROMATASE INHIBITOR;
BUSERELIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
ESTRADIOL;
ESTROGEN RECEPTOR;
FLUOROURACIL;
GONADORELIN AGONIST;
GOSERELIN;
METHOTREXATE;
PLACEBO;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CLINICAL TRIAL;
EDITORIAL;
HUMAN;
OVARIECTOMY;
POSTMENOPAUSE;
PREMENOPAUSE;
PRIORITY JOURNAL;
SURVIVAL TIME;
|
|
EID: 0034616664
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/92.11.859 Document Type: Editorial |
|
Times cited : (13)
|
|
References (15)
|
